Korro Bio (KRRO) news
Recent news
Korro Bio reports inducement grant under Nasdaq listing rule 5635(c)(4)
Korro Bio, Inc. (Nasdaq: KRRO) has announced the issuance of non-statutory stock options to newly hired employees as part of its compliance with Nasdaq Listing Rule 5635(c)(4). On April 8, 2026, the company granted a non-statutory stock option to one employee to purchase 15,000 shares of common…
AInvest Wire · Aug 14, 2026ImportantKorro Bio shares up 32%, triggering trading halt
Korro Bio shares up 32%, triggering trading halt Korro Bio, Inc. (KRRO), a pioneering biopharmaceutical company specializing in the discovery, development, and commercialization of RNA editing-based genetic medicines, experienced a significant surge in its share price on [date], rising by 32% and…
AInvest Wire · Oct 16, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.